ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

NCI-Approved Clinical Trials

August 25, 2006

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

April 17, 1981

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011